Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
01/25/2011 | CA2469594C Crystal of bicalutamide and production method thereof |
01/25/2011 | CA2441834C Lipid profile modulation |
01/25/2011 | CA2434299C Tricyclic androgen receptor modulator compounds and methods |
01/20/2011 | WO2011007865A1 Agent for inhibiting increase in postprandial blood insulin level |
01/20/2011 | WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
01/20/2011 | WO2011006497A1 Acylated glucagon analogues |
01/20/2011 | WO2010032006A3 Treatment of adrenal insufficiency |
01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
01/20/2011 | US20110015276 Therapeutical uses of inecalcitol |
01/20/2011 | US20110015210 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
01/20/2011 | US20110015164 Method of treating men with metabolic and anthropometric disorders |
01/20/2011 | US20110015161 Pharmaceutical containing a horomone combination having a contraceptive effecr and an insulin sensitizer |
01/20/2011 | US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK |
01/20/2011 | US20110014251 Microvesicles |
01/20/2011 | US20110014200 Monoclonal antibody that suppresses thyrotropin receptor constitutive activity |
01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
01/20/2011 | US20110014160 DDR1-Mediated Cell Purification of Pancreatic Endocrine Cells Through Their Progenitors |
01/20/2011 | CA2767792A1 Acylated glucagon analogues |
01/20/2011 | CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
01/19/2011 | EP2275557A1 Albumin fusion proteins |
01/19/2011 | EP2275439A2 Novel insulin derivatives |
01/19/2011 | EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders |
01/19/2011 | EP2274978A1 Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency |
01/19/2011 | EP2274316A1 Ligands of estrogen receptors and , method of their preparation and pharmaceuticals comprising them |
01/19/2011 | EP1547614B1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof |
01/19/2011 | CN101948539A IL-18 binding proteins |
01/19/2011 | CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof |
01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
01/19/2011 | CN101947310A Adrenocorticotropic hormone analogs and related methods |
01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
01/19/2011 | CN101947231A Medicament for emasculating sows |
01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
01/18/2011 | US7871994 at least one ingestion period preceding the permanent administration of hormone daily units has an ingestion pause in which either no daily units or units with a much lower hormone content is given |
01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
01/18/2011 | CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist |
01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
01/13/2011 | WO2011005969A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
01/13/2011 | US20110010784 Insulin-like gene of prawns and uses thereof |
01/13/2011 | US20110009443 Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors |
01/13/2011 | US20110009428 Novel androgens |
01/13/2011 | US20110009427 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
01/13/2011 | US20110009347 Combination therapy for the treatment of diabetes |
01/13/2011 | US20110009318 Transdermal Compositions and Methods for Treatment of Fibromyalgia and Chronic Fatigue Syndrome |
01/13/2011 | US20110008464 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
01/13/2011 | US20110008423 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
01/13/2011 | US20110008395 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
01/13/2011 | US20110008297 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
01/13/2011 | CA2767112A1 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
01/13/2011 | CA2766008A1 Composition for the treatment of benign prostate hyperplasia |
01/12/2011 | EP2272875A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
01/12/2011 | EP2271405A2 Nip thiazole derivatives as inhibitors of 11-beta-hydorxysteroid dehydrogenase-1 |
01/12/2011 | EP2271320A1 Raloxifene pharmaceutical formulations |
01/12/2011 | EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
01/12/2011 | EP1272206B1 A chicken II GnRH analog for use in reducing tumor cell growth |
01/12/2011 | CN101945853A Selective androgen receptor modulators (sarms) and uses thereof |
01/12/2011 | CN101940550A Preparation method of gonadotropin releasing hormone liposome |
01/11/2011 | US7868193 Contraceptives; hormone replacement therapy |
01/11/2011 | US7867990 Steroid hormone products and methods for preparing them |
01/11/2011 | US7867986 Enhanced drug delivery in transdermal systems |
01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
01/06/2011 | WO2011002332A1 Synthetic peptides having anti-stress activity |
01/06/2011 | WO2011002001A1 Combined medicine of pyrazole derivative and biguanide drug |
01/06/2011 | WO2011000210A1 Composition of permeation enhancer and use thereof in transdermal drug delivery system |
01/06/2011 | WO2010130980A3 A fertilized, incubated avian egg or extract for the treatment of stress |
01/06/2011 | WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors |
01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
01/06/2011 | US20110003782 23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof |
01/06/2011 | US20110003750 Human 3 relaxin |
01/06/2011 | US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof |
01/06/2011 | US20110003746 Protein variants |
01/06/2011 | US20110002965 Immunomodulating compounds and related compositions and methods |
01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
01/05/2011 | EP2269613A2 Solid orald dosage form comprising a combination of metformin and glibenclamide |
01/05/2011 | CN101935656A Gene for promoting insulin secretion, preparation method and application thereof |
01/05/2011 | CN101935301A Modulators of ATP-binding cassette transporters |
01/05/2011 | CN101934078A Pharmaceutical composition comprising drospirenone and estrogen, and application thereof |
01/05/2011 | CN101934015A Traditional Chinese medicinal composition for treating thyroid and method for preparing dispelling-goitre cataplasm thereof |
01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
01/04/2011 | CA2456901C Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity |